Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Boaz, M; Smetana, S; Weinstein, T; Matas, Z; Gafter, U; Iaina, A; Knecht, A; Weissgarten, Y; Brunner, D; Fainaru, M; Green, M S
The Lancet , Volume 356 (9237): -1204 – Nov 30, 2000
Download PDF
Loading next page...
 
/lp/pubmed/secondary-prevention-with-antioxidants-of-cardiovascular-disease-in-p5morSsHTp

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0140-6736
DOI
10.1016/s0140-6736(00)02783-5
pmid
11072938

Abstract

Journal

The Lancet – Pubmed

Published: Nov 30, 2000

There are no references for this article.